The Promise of FTD Research Trials: A Webinar on December 7, 2022
The science of FTD is quickly evolving. While several years ago, there were no experimental treatments for FTD, there are now many medications being tested in clinical trials. The next Perspectives in FTD Research webinar on Dec. 7, 2022, will discuss “The Promise of FTD Research Trials: What should I know about current drug studies?” more >
FEATURED RESEARCHER: Dr. Peter Ljubenkov
Whether seeing patients for clinical trials or spending time with his family, Peter Ljubenkov, M.D., lives life with his heart. As a behavioral neurologist at the Memory and Aging Center at UCSF, he specializes in caring for patients experiencing memory, language, and behavioral changes due to neurological conditions. more >
Featured Study: Veri-T
A new clinical trial that is testing a known drug hopes to slow the progression of semantic variant primary progressive aphasia (svPPA). A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology, the Veri-T Study for short, is the first trial focusing on persons with svPPA. more >
International FTD Caregiver Day Meeting: Friday, November 4, 2022
ISFTD Congress offers in-person and virtual events at no cost. Caregiver Day offers in-person and virtual options for family members and professional caregivers to attend on Friday, November 4, 2022. more >
CurePSP Fall Family Conference: November 14, 2022
The CurePSP Fall Family Conference will be held in person at the Airport Marriott in Philadelphia, Pennsylvania on Monday, November 14, 2022. Early bird registration is $15 per person. Cost is $30 per... more >